Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.
Oerter
K E
KE
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Manasco
P K
PK
Barnes
K M
KM
Jones
J
J
Hill
S
S
Cutler
G B
GB
D000328:Adult; D000365:Age Determination by Skeleton; D000367:Age Factors; D001827:Body Height / Q000187:drug effects*; D002064:Buserelin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017274:Nafarelin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011379:Prognosis; D011629:Puberty, Precocious / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D017329:Triptorelin Pamoate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use / Q000031:analogs & derivatives
D017329:Triptorelin Pamoate; D017274:Nafarelin; D007987:Gonadotropin-Releasing Hormone; C029256:histrelin; D002064:Buserelin; C066438:deslorelin